PG AYUSH Admissions 2025: AACCC begins Round 2 allotment, round 3 registrations from October 21st

New Delhi- The AYUSH Admissions Central Counselling Committee (AACCC) has commenced the seat allotment process today for the second round of registration for Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy…

Continue ReadingPG AYUSH Admissions 2025: AACCC begins Round 2 allotment, round 3 registrations from October 21st

NMC reopens portal for eligibility certificates applications, check details

New Delhi: Through a public notice, the Ethics and Medical Registration Board (EMRB) of the National Medical Commission (NMC) has announced an additional opportunity for candidates seeking the Eligibility Certificate. This comes…

Continue ReadingNMC reopens portal for eligibility certificates applications, check details

Once patient undergoes treatment, surgery based on doctor’s advice, insurer cannot arbitrarily reject claim: Kerala HC

Ernakulam: The Kerala High Court bench recently ruled that once an insured person has undergone treatment or surgery based on the expert opinion of a doctor, the insurer cannot arbitrarily reject…

Continue ReadingOnce patient undergoes treatment, surgery based on doctor’s advice, insurer cannot arbitrarily reject claim: Kerala HC

NEET PG: KNRUHS invites online applications for PG medical admissions under Management quota, check details

Telangana: The Kaloji Narayan Rao University of Health Sciences (KNRUHS) is inviting online applications from the National Eligibility and Entrance Test-Postgraduate (NEET PG) for the academic year 2025. The applications can be submitted…

Continue ReadingNEET PG: KNRUHS invites online applications for PG medical admissions under Management quota, check details

Vildagliptin-Dapagliflozin FDC Effective in High CV Risk Indian T2DM Patients: Findings from Latest DAa-ViNCI Study

In a new study, fixed-dose combination (FDC) of vildagliptin and dapagliflozin demonstrated substantial efficacy and good tolerability in managing Type 2 Diabetes Mellitus (T2DM). The recent study titled, "DApagliflozin 10…

Continue ReadingVildagliptin-Dapagliflozin FDC Effective in High CV Risk Indian T2DM Patients: Findings from Latest DAa-ViNCI Study